Viewing nowGlimil Tablet (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.

MFDS item code 200400660 · Approved 2004.09.03 · Insurance code 649600040
Improvement of blood glucose control in type 2 diabetes mellitus
This medication is used to improve blood sugar control in patients with type 2 diabetes. It is administered as an adjunct to dietary therapy and exercise to help manage blood sugar effectively. It can also be used as monotherapy, and if blood sugar control is insufficient, it can be combined with other oral hypoglycemic agents or insulin. Especially when efficacy is lacking with sulfonylureas or metformin alone, it can be combined with metformin to improve blood sugar control. This medication helps patients manage their blood sugar more stably and aids in diabetes treatment.
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 glass of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received drug therapy, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional effect, although some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic agent. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering agent to this medicine There is no exact dose equivalence between this medicine and other oral glucose-lowering agents. When switching from another oral glucose-lowering agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medicine should be taken into account. 4) Dose adjustment During treatment with this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Initiate insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for glycemic control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a state of coma. Patients who have had allergic reactions to this medication or to sulfonylureas or sulfonamides should also not be administered this medication. There is no experience of use in patients with severely impaired liver or kidney function, and in such cases, transitioning to insulin therapy is recommended. Women who are pregnant or may become pregnant, as well as those who are breastfeeding, should not take this medication. In patients with severe infections, before and after surgery, or in cases of severe trauma, insulin therapy is needed, so this medication should not be used. Patients with gastrointestinal disorders such as diarrhea or vomiting may experience absorption issues, leading to an increased risk of hypoglycemia, so caution is advised. During the first week of taking this medication, there is an increased risk of hypoglycemia, so blood sugar levels should be monitored closely. Special caution should be taken for the elderly, those in poor nutritional status or who eat irregularly, as well as those who frequently consume alcohol, as they are at higher risk for hypoglycemia. Patients with weakened kidney or liver function or other endocrine disorders may also respond sensitively to this medication, requiring caution. Additionally, when taking this medication with other drugs, it is essential to inform your doctor or pharmacist due to potential interactions affecting blood sugar control. This medication has blood sugar-lowering effects, so hypoglycemic symptoms may occur. Symptoms may include headache, severe hunger, nausea, fatigue, anxiety, decreased concentration, dizziness, confusion, drowsiness, loss of consciousness, among others. In severe cases, it can lead to seizures or coma, so if symptoms occur, immediately consume sugar or seek medical assistance. Moreover, temporary blurred vision can occur in the initial stages of taking this medication, and gastrointestinal issues, liver function abnormalities, blood abnormalities, and allergic reactions may rarely occur. If severe allergic symptoms or skin rashes are observed, discontinue use immediately and consult a doctor. To use this medication effectively, it should be taken regularly alongside dietary and exercise therapies. In case of hypoglycemia, foods or drinks containing sugar should be ingested promptly to restore blood sugar levels, as artificial sweeteners are ineffective. Particularly during the initial administration or when adjusting the dosage, careful observation for hypoglycemic symptoms is necessary, and caution is required when driving or operating machinery. This medication may interact with other drugs, so if you are taking other medications, it is crucial to inform your healthcare provider. Particularly, co-administration with some antibiotics, antifungals, steroids, beta-blockers, etc. can affect blood sugar regulation. Additionally, alcohol consumption can unpredictably alter the efficacy of this medication, requiring caution. Women who are pregnant or nursing should not use this medication as it may pose risks to the fetus or newborn, and switching to insulin therapy is advisable. The safety and efficacy of this medication in children under 18 years old have not been established, so it should not be used in this age group. Elderly patients may have decreased kidney function, so careful dose adjustment is necessary, with particular attention to the risk of hypoglycemia. In case of overdose, severe hypoglycemia may occur, requiring immediate medical attention for appropriate treatment. This medication should be stored out of reach of children and kept in its original container to maintain its quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain the storage temperature between 1 to 30 degrees Celsius.
Green rectangular tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.